Search

Your search keyword '"Roosendaal, Stefan"' showing total 225 results

Search Constraints

Start Over You searched for: Author "Roosendaal, Stefan" Remove constraint Author: "Roosendaal, Stefan"
225 results on '"Roosendaal, Stefan"'

Search Results

4. Collateral-based selection for endovascular treatment of acute ischaemic stroke in the late window (MR CLEAN-LATE): 2-year follow-up of a phase 3, multicentre, open-label, randomised controlled trial in the Netherlands

6. Intravenous Thrombolysis Before Endovascular Treatment in Posterior Circulation Occlusions: A MR CLEAN Registry Study

7. Prediction of Outcome and Endovascular Treatment Benefit

8. Endovascular treatment versus no endovascular treatment after 6–24 h in patients with ischaemic stroke and collateral flow on CT angiography (MR CLEAN-LATE) in the Netherlands: a multicentre, open-label, blinded-endpoint, randomised, controlled, phase 3 trial

10. Prognostic Value of Thrombus Volume and Interaction With First-Line Endovascular Treatment Device Choice

11. Prehospital transdermal glyceryl trinitrate in patients with presumed acute stroke (MR ASAP): an ambulance-based, multicentre, randomised, open-label, blinded endpoint, phase 3 trial

12. Safety and efficacy of aspirin, unfractionated heparin, both, or neither during endovascular stroke treatment (MR CLEAN-MED): an open-label, multicentre, randomised controlled trial

13. Pontocerebellar hypoplasia due to bi-allelic variants in MINPP1

14. Improvements in Endovascular Treatment for Acute Ischemic Stroke: A Longitudinal Study in the MR CLEAN Registry

18. Association between thrombus composition and stroke etiology in the MR CLEAN Registry biobank

19. Applicability of multiple quantitative magnetic resonance methods in genetic brain white matter disorders.

21. Continuing Challenges in the Definitive Diagnosis of Cushing’s Disease: A Structured Review Focusing on Molecular Imaging and a Proposal for Diagnostic Work-Up

22. Validity of Early Outcomes as Indicators for Comparing Hospitals on Quality of Stroke Care

23. Endovascular treatment versus no endovascular treatment after 6–24 h in patients with ischaemic stroke and collateral flow on CT angiography (MR CLEAN-LATE) in the Netherlands:a multicentre, open-label, blinded-endpoint, randomised, controlled, phase 3 trial

24. Safety and Efficacy of Dual Thrombolytic Therapy With Mutant Prourokinase and Small Bolus Alteplase for Ischemic Stroke:A Randomized Clinical Trial

25. Type of intracranial hemorrhage after endovascular stroke treatment:association with functional outcome

26. Prognostic Value of Thrombus Volume and Interaction With First-Line Endovascular Treatment Device Choice

27. Workflow Intervals of Endovascular Acute Stroke Therapy During On- Versus Off-Hours: The MR CLEAN Registry

28. Type of intracranial hemorrhage after endovascular stroke treatment: association with functional outcome.

30. Effect of Intravenous Alteplase Treatment on First-Line Stent Retriever Versus Aspiration Alone During Endovascular Treatment

31. Type of intracranial hemorrhage after endovascular stroke treatment: association with functional outcome

32. Determinants of Symptomatic Intracranial Hemorrhage After Endovascular Stroke Treatment: A Retrospective Cohort Study

33. Time to Endovascular Treatment and Outcome in Acute Ischemic Stroke: MR CLEAN Registry Results

34. Safety and Efficacy of Dual Thrombolytic Therapy With Mutant Prourokinase and Small Bolus Alteplase for Ischemic Stroke: A Randomized Clinical Trial.

35. Etiology of Large Vessel Occlusion Posterior Circulation Stroke: Results of the MR CLEAN Registry

36. Estimation of treatment effects in observational stroke care data: comparison of statistical approaches

37. Safety and efficacy of aspirin, unfractionated heparin, both, or neither during endovascular stroke treatment (MR CLEAN-MED):an open-label, multicentre, randomised controlled trial

38. Improvements in Endovascular Treatment for Acute Ischemic Stroke:A Longitudinal Study in the MR CLEAN Registry

40. Endovascular Treatment for Posterior Circulation Stroke in Routine Clinical Practice: Results of the Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands Registry

42. Hospital Variation in Time to Endovascular Treatment for Ischemic Stroke: What Is the Optimal Target for Improvement?

43. White Matter Lesions and Outcomes After Endovascular Treatment for Acute Ischemic Stroke: MR CLEAN Registry Results

45. Effect of First‐Pass Reperfusion on Outcome After Endovascular Treatment for Ischemic Stroke

46. Craniofaryngiomen: Craniofaryngiomen zijn zeldzame benigne tumoren in de (supra)sellaire regio. Ze komen voor bij personen op iedere leeftijd, met een piek tussen 5–14 jaar en 50–75 jaar. Door hun trage groei duurt het vaak lang voordat de diagnose wordt gesteld. Symptomen worden veroorzaakt door druk op het optische systeem en/of disfunctie van de hypofyse/hypothalamus. De behandeling bestaat meestal uit een combinatie van chirurgie en radiotherapie. De kans op genezing is hoog (90% 10-jaarsoverleving), maar de kwaliteit van leven kan fors beperkt zijn

47. Deep phenotyping classical galactosemia: clinical outcomes and biochemical markers

48. Deep phenotyping classical galactosemia: clinical outcomes and biochemical markers

49. Importance of Occlusion Site for Thrombectomy Technique in Stroke

50. Gray and white matter are both affected in classical galactosemia: An explorative study on the association between neuroimaging and clinical outcome

Catalog

Books, media, physical & digital resources